PER 0.00% 10.0¢ percheron therapeutics limited

Sarpeta have run rough-shod over the FDA's concerns for years,...

  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    Sarpeta have run rough-shod over the FDA's concerns for years, and I truly hope it is the end of the road for them.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.